Quantitative Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Quantitative Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,352	Closed	-$273K	–	360
2026 Q1	$273K	Buy	+10,352	New	+$303K	0.03%	350
2025 Q4	–	Sell	-19,047	Closed	-$528K	–	382
2025 Q3	$528K	Buy	19,047 +8,938	+88%	+$226K	0.07%	224
2025 Q2	$246K	Buy	+10,109	New	+$222K	0.03%	267
2024 Q4	–	Sell	-35,633	Closed	-$912K	–	322
2024 Q3	$912K	Sell	35,633 -46,516	-57%	-$1.18M	0.09%	179
2024 Q2	$1.93M	Buy	+82,149	New	+$2.07M	0.21%	97
2023 Q3	–	Sell	-100,409	Closed	-$3.42M	–	176
2023 Q2	$3.42M	Buy	+100,409	New	+$3.16M	0.32%	68

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Quantitative Investment Management's ARKG Position: Q2 2026 in Review

Quantitative Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 10,352 shares — an estimated $273K sold.

Quantitative Investment Management first reported a position in ARKG in Q2 2023 and held it in 6 quarters. The position peaked at $3.42M in Q2 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Quantitative Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Quantitative Investment Management sold 10,352 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $273K.
Quantitative Investment Management first reported a position in ARK Genomic Revolution ETF in Q2 2023 and held it in 6 quarters.
Quantitative Investment Management's ARK Genomic Revolution ETF position peaked at $3.42M in Q2 2023.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.